Dexmedetomidine and Magnesium Sulfate in Preventing Junctional Ectopic Tachycardia After Pediatric Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

September 15, 2023

Conditions
Post Operative Arrythmia
Interventions
DRUG

Dexmedetomidine

dexmedetomidine 0.5 µg/kg diluted in 50 mL of normal saline intravenously over 20 minutes, After induction followed by 0.5 µg/kg per hour infusion for 72 hours postoperatively or ready for extubation prior to 72 hour time period

DRUG

Magnesium sulfate

Magnesium Sulfate (50 mg/kg) bolus administered at the time of Aortic Cross Clamp Release. with continued administration for 72 hours postoperatively at a dose of 30 mg/kg/day.

Trial Locations (1)

Unknown

Kasralainy Faculty of Medicine, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER